Filing Details

Accession Number:
0001209191-22-017635
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-09 17:34:11
Reporting Period:
2022-03-07
Accepted Time:
2022-03-09 17:34:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1786255 Icosavax Inc. ICVX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1874017 Cassia Cearley C/O Icosavax, Inc.
1616 Eastlake Avenue E., Suite 208
Seattle WA 98102
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-07 9,516 $17.13 98,897 No 4 S Direct
Common Stock Disposition 2022-03-07 484 $17.81 98,413 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.71 and $17.63. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
  3. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.78 and $17.88. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.